02/15/2012 06:43 am ET

Johnson & Johnson Sold Hip Implants Abroad After FDA Rejected Sale In The U.S. For Safety Concerns

The health care products giant Johnson & Johnson continued to market an artificial hip in Europe and elsewhere overseas after the Food and Drug Administration rejected its sale in the United States based on a review of company safety studies.

Read more on The New York Times